Imaging Depression: New Biological Markers May Mean More Targeted Treatments are Just over the Horizon.
In: IEEE Pulse, Jg. 8 (2017-11-01), Heft 6, S. 19-22
Online
academicJournal
Zugriff:
On a balmy evening in mid-May 2017, Chris Cornell, the legendary head of the internationally renowned rock band Soundgarden, strummed his last chord at the Fox Theater in Detroit and headed to the MGM Grand Hotel. According to the police report, he swallowed a few tablets of the antidepression drug Ativan in his room and called his wife. "I'm just tired," he said and hung up the phone. Later that night, at the request of his concerned wife, his bodyguard forced open Cornell's door to discover him on the bathroom floor, an exercise band tied around his neck. His death was ruled a suicide by hanging, the conclusion of a life riddled with drug abuse and a depression he'd never managed to shake. [ABSTRACT FROM PUBLISHER]
Copyright of IEEE Pulse is the property of IEEE and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Imaging Depression: New Biological Markers May Mean More Targeted Treatments are Just over the Horizon.
|
---|---|
Autor/in / Beteiligte Person: | Berglund, Jennifer |
Link: | |
Zeitschrift: | IEEE Pulse, Jg. 8 (2017-11-01), Heft 6, S. 19-22 |
Veröffentlichung: | 2017 |
Medientyp: | academicJournal |
ISSN: | 2154-2287 (print) |
DOI: | 10.1109/MPUL.2017.2751119 |
Schlagwort: |
|
Sonstiges: |
|